Literature DB >> 11129319

Phenotypic markers as risk factors in schizophrenia: neurocognitive functions.

P T Michie1, A Kent, R Stienstra, R Castine, J Johnston, K Dedman, H Wichmann, J Box, D Rock, E Rutherford, A Jablensky.   

Abstract

OBJECTIVE: To review the literature on neurocognitive measures as risk markers for schizophrenia and to present data from the Perth family study of schizophrenia. Of all the risk markers that have been identified, the most promising are deficits in sustained attention.
METHOD: Inclusion in the review was determined by whether the research addressed a number of key questions: methods of assessing sustained attention; evidence of sustained attention deficits in patients and first-degree relatives including children; the importance of attentional dysfunction in the schizophrenic process and functional outcome; and the biological basis of sustained attention deficits.
RESULTS: Sustained attention deficits are evident in both patients and a proportion of their first-degree relatives, a finding replicated in preliminary data from the Perth family study. The literature suggests that the attention deficit is a stable enduring trait that is independent of clinical state. The neural basis of the deficit may be a functional disconnection between prefrontal and parietal cortex. Attention impairment is an important predictor of functional outcome in patients and the development of social dysfunction in adulthood in the at-risk offspring of patients. However, sustained attention deficits that are measured in childhood results in an unacceptable high false-positive rate (21%) when predicting which at-risk offspring of parents with schizophrenia will develop a schizophrenia spectrum disorder, although the overall classification accuracy (78%) is impressive.
CONCLUSIONS: The main findings are that sustained attention deficits are important risk markers for schizophrenia but need to be supplemented by other neurocognitive risk markers to improve predictive accuracy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129319     DOI: 10.1080/000486700226

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  14 in total

Review 1.  Approaches for adolescents with an affected family member with schizophrenia.

Authors:  Vaibhav A Diwadkar; Konasale M Prasad; Matcheri S Keshavan
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 5.285

2.  Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study.

Authors:  Matcheri S Keshavan; Vaibhav A Diwadkar; Debra M Montrose; Jeff A Stanley; Jay W Pettegrew
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

3.  Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?

Authors:  Stephen M Lawrie; Bayanne Olabi; Jeremy Hall; Andrew M McIntosh
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

Review 4.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

5.  A developmental look at the attentional system in the at risk and first episode of psychosis: age related changes in attention along the psychosis spectrum.

Authors:  Heline Mirzakhanian; Fiza Singh; Katherine Seeber; Kathleen M Shafer; Kristin S Cadenhead
Journal:  Cogn Neuropsychiatry       Date:  2012-09-21       Impact factor: 1.871

6.  Assessment of Cognition and Personality as Potential Endophenotypes in the Western Australian Family Study of Schizophrenia.

Authors:  Nina S McCarthy; Johanna C Badcock; Melanie L Clark; Emma E M Knowles; Gemma Cadby; Phillip E Melton; Vera A Morgan; John Blangero; Eric K Moses; David C Glahn; Assen Jablensky
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

7.  Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia.

Authors:  Zainab Delawalla; Deanna M Barch; Jennifer L Fisher Eastep; Emily S Thomason; Melissa J Hanewinkel; Paul A Thompson; John G Csernansky
Journal:  Schizophr Bull       Date:  2006-05-19       Impact factor: 9.306

8.  Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers.

Authors:  Vaibhav A Diwadkar; Dhruman Goradia; Avinash Hosanagar; Diana Mermon; Debra M Montrose; Boris Birmaher; David Axelson; R Rajarathinem; Luay Haddad; Ali Amirsadri; Caroline Zajac-Benitez; Usha Rajan; Matcheri S Keshavan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-04-28       Impact factor: 5.067

Review 9.  Neurocognitive allied phenotypes for schizophrenia and bipolar disorder.

Authors:  S Kristian Hill; Margret S H Harris; Ellen S Herbener; Mani Pavuluri; John A Sweeney
Journal:  Schizophr Bull       Date:  2008-04-29       Impact factor: 9.306

10.  Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia.

Authors:  Yuko Higuchi; Tomiki Sumiyoshi; Takahiro Tateno; Suguru Nakajima; Daiki Sasabayashi; Shimako Nishiyama; Yuko Mizukami; Tsutomu Takahashi; Michio Suzuki
Journal:  J Pers Med       Date:  2021-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.